These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 19545047

  • 1. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN, Shen Q, Li SS.
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [Abstract] [Full Text] [Related]

  • 2. [Progress in the study of micelle delivery system reversing multidrug resistance].
    Diao YY, Han M, Chen DW, Gao JQ.
    Yao Xue Xue Bao; 2009 Jul; 44(7):710-5. PubMed ID: 19806907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nanoparticles for drug delivery in cancer treatment.
    Haley B, Frenkel E.
    Urol Oncol; 2008 Jul; 26(1):57-64. PubMed ID: 18190833
    [Abstract] [Full Text] [Related]

  • 8. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y, Loizidou M, Seifalian AM.
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
    Yadav S, van Vlerken LE, Little SR, Amiji MM.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):711-22. PubMed ID: 18618115
    [Abstract] [Full Text] [Related]

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):491-504. PubMed ID: 17532091
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G, Hatakeyama H, Harashima H.
    Arch Pharm Res; 2014 Jan 10; 37(1):4-15. PubMed ID: 24272889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L, Blanchette JO.
    Adv Drug Deliv Rev; 2004 Sep 22; 56(11):1649-59. PubMed ID: 15350294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.